BioCentury | Jan 21, 2021
Management Tracks

MacDonald to succeed retiring Ostrach as Dynavax CFO; plus Antibiotic Resistance UK, Arix, Viridian, Avrobio, Imago, ONL, Atea, Chiasma, Tiziana, Elevar,  and Imara

...its advanced program in Fabry disease closer to approval. Escolar was CMO at miRagen.Ann Arbor-based ONL Therapeutics Inc....
...research at Acceleron Pharma Inc. (NASDAQ:XLRN).TARGETSFASN (FAS) – Fatty acid synthase BC Staff Dynavax Technologies Corp. Avrobio Inc. Imago BioSciences Inc. ONL Therapeutics Inc. miRagen...
BioCentury | Dec 21, 2020
Finance

Dec. 21-23 Financial Quick Takes: Venture rounds for SomaLogic, ONL; plus Jacobio’s HK listing, Cullinan, Gracell and Zhaoke file for IPOs, and more

...Capital, PSQ Capital and Michigan Capital Network Venture Fund III. Existing investors in round included ONL Therapeutics...
BioCentury | Jun 19, 2019
Company News

Management tracks: Ultragenyx promotes Erik Harris; plus F-star, Arbutus, Maze and more

...Homcy, who will become chairman. Homcy is a partner at Third Rock. Retinal disease company ONL Therapeutics Inc....
...Block, Associate Editor Arbutus Biopharma Arbutus Biopharma Corp. F-star Biotechnology F-star Biotechnology Ltd. Maze Therapeutics Menlo Therapeutics Menlo Therapeutics Inc. Millendo Therapeutics Millendo Therapeutics Inc. ONL Therapeutics ONL Therapeutics Inc. Ultragenyx Ultragenyx...
BioCentury | Feb 13, 2019
Distillery Therapeutics

Cancer

...also has the product in Phase I testing for myelodysplastic syndrome (MDS) and solid tumors. ONL Therapeutics Inc....
BioCentury | Jun 9, 2017
Financial News

ONL Therapeutics raises $4.3M in series A

...On May 17, ophthalmic company ONL Therapeutics Inc. (Ann Arbor, Mich.) raised $4.3 million in a series A...
...Michigan, Biosciences Research & Commercialization Center and Hestia Investments. ONL Therapeutics Inc. , Ann Arbor, Mich. Mary Romeo Novartis AG ONL Therapeutics Inc. University...
BioCentury | Mar 30, 2017
Financial News

ONL Therapeutics completes venture financing

...On March 21, retinal disease company ONL Therapeutics Inc. (Ann Arbor, Mich.) said it recently raised more than...
...investors, including Novartis AG and Invest Michigan, and existing investors. ONL Therapeutics Inc. , Ann Arbor, Mich. Alex Himes ONL Therapeutics Inc....
BioCentury | Dec 15, 2014
Company News

ONL Therapeutics LLC management update

ONL Therapeutics LLC , Ann Arbor, Mich. Business: Ophthalmic Hired: Linda Johnson as SVP of operations, formerly executive director of worldwide development at Pfizer Inc. Transitioned: David Zacks to CSO from president and CMO; he is...
BioCentury | Jun 24, 2013
Company News

ONL Therapeutics management update

ONL Therapeutics LLC , Ann Arbor, Mich. Business: Ophthalmic Deceased: CEO Raili Kerppola WIR Staff...
BioCentury | Jun 10, 2013
Emerging Company Profile

ONL Therapeutics: Eyeing Fas

...Michigan and MEEI. Companies and Institutions Mentioned Massachusetts Eye and Ear Infirmary , Boston, Mass. ONL Therapeutics...
...Ann Arbor, Mich. University of Michigan Kellogg Eye Center , Ann Arbor, Mich. Sidebars ONL Therapeutics...
Items per page:
1 - 9 of 9
BioCentury | Jan 21, 2021
Management Tracks

MacDonald to succeed retiring Ostrach as Dynavax CFO; plus Antibiotic Resistance UK, Arix, Viridian, Avrobio, Imago, ONL, Atea, Chiasma, Tiziana, Elevar,  and Imara

...its advanced program in Fabry disease closer to approval. Escolar was CMO at miRagen.Ann Arbor-based ONL Therapeutics Inc....
...research at Acceleron Pharma Inc. (NASDAQ:XLRN).TARGETSFASN (FAS) – Fatty acid synthase BC Staff Dynavax Technologies Corp. Avrobio Inc. Imago BioSciences Inc. ONL Therapeutics Inc. miRagen...
BioCentury | Dec 21, 2020
Finance

Dec. 21-23 Financial Quick Takes: Venture rounds for SomaLogic, ONL; plus Jacobio’s HK listing, Cullinan, Gracell and Zhaoke file for IPOs, and more

...Capital, PSQ Capital and Michigan Capital Network Venture Fund III. Existing investors in round included ONL Therapeutics...
BioCentury | Jun 19, 2019
Company News

Management tracks: Ultragenyx promotes Erik Harris; plus F-star, Arbutus, Maze and more

...Homcy, who will become chairman. Homcy is a partner at Third Rock. Retinal disease company ONL Therapeutics Inc....
...Block, Associate Editor Arbutus Biopharma Arbutus Biopharma Corp. F-star Biotechnology F-star Biotechnology Ltd. Maze Therapeutics Menlo Therapeutics Menlo Therapeutics Inc. Millendo Therapeutics Millendo Therapeutics Inc. ONL Therapeutics ONL Therapeutics Inc. Ultragenyx Ultragenyx...
BioCentury | Feb 13, 2019
Distillery Therapeutics

Cancer

...also has the product in Phase I testing for myelodysplastic syndrome (MDS) and solid tumors. ONL Therapeutics Inc....
BioCentury | Jun 9, 2017
Financial News

ONL Therapeutics raises $4.3M in series A

...On May 17, ophthalmic company ONL Therapeutics Inc. (Ann Arbor, Mich.) raised $4.3 million in a series A...
...Michigan, Biosciences Research & Commercialization Center and Hestia Investments. ONL Therapeutics Inc. , Ann Arbor, Mich. Mary Romeo Novartis AG ONL Therapeutics Inc. University...
BioCentury | Mar 30, 2017
Financial News

ONL Therapeutics completes venture financing

...On March 21, retinal disease company ONL Therapeutics Inc. (Ann Arbor, Mich.) said it recently raised more than...
...investors, including Novartis AG and Invest Michigan, and existing investors. ONL Therapeutics Inc. , Ann Arbor, Mich. Alex Himes ONL Therapeutics Inc....
BioCentury | Dec 15, 2014
Company News

ONL Therapeutics LLC management update

ONL Therapeutics LLC , Ann Arbor, Mich. Business: Ophthalmic Hired: Linda Johnson as SVP of operations, formerly executive director of worldwide development at Pfizer Inc. Transitioned: David Zacks to CSO from president and CMO; he is...
BioCentury | Jun 24, 2013
Company News

ONL Therapeutics management update

ONL Therapeutics LLC , Ann Arbor, Mich. Business: Ophthalmic Deceased: CEO Raili Kerppola WIR Staff...
BioCentury | Jun 10, 2013
Emerging Company Profile

ONL Therapeutics: Eyeing Fas

...Michigan and MEEI. Companies and Institutions Mentioned Massachusetts Eye and Ear Infirmary , Boston, Mass. ONL Therapeutics...
...Ann Arbor, Mich. University of Michigan Kellogg Eye Center , Ann Arbor, Mich. Sidebars ONL Therapeutics...
Items per page:
1 - 9 of 9